DarioHealth Corp. Amortization of Debt Issuance Costs
DarioHealth Corp. (DRIO) reported Amortization of Debt Issuance Costs of $516.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2025-03-10
- DarioHealth Corp. amortization of debt issuance costs for the quarter ending 2024-12-31 was $84.00K.
- DarioHealth Corp. amortization of debt issuance costs for the quarter ending 2024-09-30 was $228.00K.
- DarioHealth Corp. amortization of debt issuance costs for the quarter ending 2023-12-31 was -$69.00K.
- DarioHealth Corp. amortization of debt issuance costs for the quarter ending 2023-09-30 was -$234.00K.
- DarioHealth Corp. amortization of debt issuance costs for fiscal 2024 was $516.00K, a 56.93% decline from fiscal 2023.
- DarioHealth Corp. amortization of debt issuance costs for fiscal 2023 was $1.20M, a 70.43% decline from fiscal 2022.
- DarioHealth Corp. amortization of debt issuance costs for fiscal 2022 was $4.05M.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $312.00K derived: sum of 2 quarters · filed 2025-03-10 | $516.00K 10-K · filed 2025-03-10 | ||
| 2024-09-30 | $228.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $432.00K 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $204.00K 10-Q · filed 2024-08-08 | ||||
| 2023-12-31 | -$69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$303.00K derived: sum of 2 quarters · filed 2025-03-10 | $1.20M 10-K · filed 2025-03-10 | $528.00K 10-K · filed 2024-03-28 | |
| 2023-09-30 | -$234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.27M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $1.50M 10-Q · filed 2024-08-08 | ||||
| 2022-12-31 | $4.05M 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |